Background. Infective endocarditis (IE) caused by Abiotrophia (ABI) and Granulicatella (GRA) species is poorly studied. This work aims to describe and compare the main features of ABI and GRA IE.
Barcelona, Spain, from January 2000 to December 2015. The Hospital Clinic is an 800-bed, tertiary-level university hospital and a reference center for cardiac surgery in Spain.
All cases reported with the current taxonomy were included. The diagnosis of IE was made according to the modified Duke criteria [11] . Definite and probable cases were included in the final analysis. All cases were followed until December 2016.
Review of the Literature
We searched in PubMed articles published in English or Spanish languages between 1 January 2000 and 31 December 2015, using a Boolean strategy with the terms "nutritionally variant Streptococcus" or "nutritionally variant streptococci" or "abiotrophia" or "granulicatella" and "infective endocarditis. " Demographic, clinical, and microbiological data were collected in a specifically developed case report form. Descriptions were performed for all cases, and comparisons were performed according to genera.
In Vitro Susceptibility Assays
The broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of penicillin, ampicillin, ceftriaxone, gentamicin, vancomycin, daptomycin, linezolid, levofloxacin, and trimethoprim-sulfamethoxazole, according to standard recommendations [12] . A Mueller-Hinton broth (CAMHB) was supplemented with 5% lysed horse blood (Thermo Fisher Scientific, Hampshire, United Kingdom) and 1 g/mL pyridoxal hydrochloride (Sigma-Aldrich, St Louis, Missouri). Streptococcus pneumoniae ATCC 49619 served as the quality control strain.
In keeping with current guidelines [13, 14] , relapse was defined as a repeated episode of IE caused by the same microorganism within the 6 months following the initial infection, while reinfection was defined as an infection caused by a different microorganism.
Statistical Analysis
The qualitative variables were described as absolute and relative frequencies, and the quantitative variables as median and interquartile range (IQR). The comparisons of qualitative variables between groups were done with χ 2 or, where necessary, Fisher exact tests (ie, n < 30 or where absolute expected frequency by group was <5). The comparisons between groups, in the quantitative variables, were performed using the Mann-Whitney test. The odds were estimated with a 95% confidence interval (CI) to evaluate the association between binary variables and in-hospital mortality. Values of P < .05 were considered statistically significant. The analysis was performed using Stata version 14.0 software.
RESULTS

Institutional Cases
During the study period, 794 IE cases were evaluated in our institution and 12 (1.51% [95% CI, .66%-2.36%]) were due to ABI/GRA. Three (0.4%) cases were secondary to ABI and 9 (1.1%) to GRA. In the subset of community-acquired IE, a total of 532 IE cases were identified; within this subset, ABI represents 0.6% and GRA 1.7%. In the same period, 229 prosthetic IE cases were treated; 1 (0.4%) case was secondary to ABI and 3 (1.3%) were secondary to GRA infection. Forty-three IE cases were among intravenous drug users, including 2 (4.7%) GRA cases. Of the 109 IE cases related to cardiac stimulation devices, none was secondary to ABI or GRA. Baseline characteristics, clinical findings, treatment, and outcomes of these 12 cases are summarized in Tables 1 and 2 . Antimicrobial susceptibility tests were performed for 11 of the 12 strains (3 ABI and 8 GRA). The lowest median MICs were observed for sulfamethoxazole (0.02 μg/mL), penicillin (0.25 μg/mL), and ampicillin (0.25 μg/ mL). Ceftriaxone (1 μg/mL) had overall higher median MICs than penicillin, particularly for some strains of Granulicatella (2 strains had MICs of 8 μg/mL). Overall, vancomycin (1 μg/mL) had lower median MICs than daptomycin (2 μg/mL group streptococci (VGS) were diagnosed in our center. HACEK IE patients were younger than the other 2 groups (P = .007), periannular complications were more frequently recorded for ABI-GRA IE cases than in the other 2 groups (P = .008), and there was more injection drug use among patients with ABI/ GRA IE (P < .001). All other characteristics were not statistically different. These results are summarized in Table 3 .
Reported Cases in the Literature
Using our search strategy, a total of 95 articles were identified, with 51 reporting at least 1 relevant case (Supplementary Table 1 ). A total of 64 cases of ABI IE or GRA IE (according to the current taxonomy, Figure 1 ) published in the literature were added to the 12 institutional cases.
Demographic Features and Comorbidities
Thirty-eight cases (50%) of ABI IE and 38 cases (50%) of GRA IE were included in the final analysis (76 cases: 12 institutional and 64 reported in the literature). 
Clinical Presentation and Complications
Most cases were community acquired: 37 cases (97.4%) of ABI IE and 36 cases (94.7%) of GRA IE (P = .56). Healthcare-related acquisition was recorded only in 1 case per group (2.6% each; P = 1). The oral cavity was identified as the origin of bacteremia in 8 cases (21.1%) of ABI IE and in 10 cases (26.3%) of GRA IE (P = .59).
The clinical course was reported in 34 of 38 (89%) ABI IE cases and in 32 of the 38 (84%) GRA IE cases. The median duration of symptoms was 91.3 (IQR, 14-152) days for ABI IE and 60.8 (IQR, 22.5-99.8) days for GRA IE (P = .56). Fever was the most frequent symptom for both genera (P = .47). Arthralgia was significantly more frequent in ABI cases than in GRA IE cases (10 cases [29.4%] vs 2 cases [6.3%]; P = .01). The rate of new-onset heart failure, central nervous system (CNS) involvement, splenomegaly, and systemic emboli were all comparable between the 2 genera.
Microbiological Findings and Antimicrobial Therapy
Twenty-six cases of ABI IE (68%) and 22 (58%) of GRA IE reported antimicrobial susceptibility data. Most of strains isolated were penicillin sensitive in both: 22 cases (84.6%) of ABI IE and 20 cases (90.9%) of GRA IE (P = .51). The median MIC for penicillin was 0.062 (IQR, 0.032-0.25) μg/mL for ABI isolates and 0.064 (IQR, 0.06-0.25) μg/mL for GRA isolates (P = .87). The MIC for gentamicin was 0.25 (IQR, 0.015-0.25) μg/mL for ABI isolates and 2.5 (IQR, 0.625-10.0) μg/mL for GRA isolates (P = .06).
Overall, the majority of ABI and GRA IE were treated with combination antimicrobial therapy (β-lactam plus gentamicin or vancomycin plus gentamicin) in both genera: 32 (84.2%) of ABI IE and 31 (81.6%) in GRA IE (P = .76). The median duration of effective treatment was similar in both genera: 42 (IQR, 42.0-49.0) days in ABI IE and 41.5 (IQR, 28.0-42.0) days in GRA IE (P = .10).
Outcome
Surgery was indicated in 28 cases (73.7%) of ABI IE and in 28 cases (73.7%) of GRA IE (P = 1.000). Surgery was performed in similar number in both genera: 25 cases (67.6%) of ABI IE (n = 37) and 25 cases (65.8%) of GRA IE (P = .87). The most frequent indication for cardiac surgery was heart failure in 14 (56% of procedures) ABI IE cases and in 17 (68% of procedures) GRA IE cases (P = .32), followed by prevention of embolic events in 7 (28% of procedures) ABI IE cases and in 6 (24%) GRA IE cases (P = .70). Overall, 7 (9.2%) of 76 patients died, 5 patients (13.2%) in the ABI group and 2 (5.3%) in the GRA IE group (P = .23). 
Prognostic Factors
The factors that influenced in-hospital mortality in the bivariate analysis were age (OR, Table 5 .
DISCUSSION
ABI and GRA IE remain rare and poorly studied. To the best of our knowledge, this study covers the largest series of IE due to ABI or GRA reported for a single institution and the most exhaustive comprehensive review of published cases. In our center, ABI/GRA IE were approximately twice as frequent as HACEK group IE, and approximately 10 times less frequent than VGS IE. The overall characteristics were quite comparable to VGS IE, although periannular complications were more frequently found in the ABI/GRA IE group. Patients were older compared to HACEK IE cases and injection drug use was more frequent among ABI/GRA cases.
According to our results, IE caused by ABI and GRA genera presents, overall, similar clinical features and outcomes. Mortality was low, overall, compared to other more frequent causes of IE. Although slightly higher for ABI cases, the numbers were too small to find a significant difference. The ratios of PVE were similar in both (ABI 13.2% vs GRA 15.8%) and there was only 1 case of intracardiac device involvement (GRA 2.7%) in the series. The presence of congenital heart disease as a risk factor was more frequent in GRA than in ABI. Mitral valve involvement was more frequent with ABI than with GRA but was similar to a recently reported series of GRA IE [15] . Multiple complications have been reported in IE caused by these organisms [16] [17] [18] [19] . New-onset heart failure was the most frequent complication in our study following of CNS embolization and hemorrhaging. The ratio of heart failure was similar in both genera and was comparable to that reported in IE due to other more frequent causes [10, 20] .
The antimicrobial susceptibility of these microorganisms has shown discrepant results [21, 22] . The patterns of resistance were elucidated in a recent study [23] . In 132 clinical, formerly NVS blood isolates, all were susceptible to vancomycin and none displayed high-level resistance to aminoglycosides. Granulicatella adiacens was considerably more susceptible to penicillin than A. defectiva (38.9% vs 10.8%), but was less susceptible to cephalosporins than was A. defectiva (43.3% vs 100% susceptible to ceftriaxone). Several isolates were resistant to levofloxacin (6%), erythromycin (51%), and clindamycin (10%). In another study [21] , resistance to β-lactam antibiotics was reported in both G. adiacens (susceptibility rates of 55%-67% to penicillin, 0%-63% to ceftriaxone, 81% to amoxicillin, and 96% to meropenem) and G. elegans (susceptibility rates of 100% to penicillin and 33% to ceftriaxone). In our institutional series, 2 Granulicatella strains had MICs as high as 8 μg/mL for ceftriaxone. Sulphonamides had extremely low MICs, and they might be useful alternative drugs, although experience with ABI/ GRA IE is lacking. It should be highlighted, however, that cutoff points have not been established for these pathogens, and most information is extrapolated from α-hemolytic streptococci.
However, it is not clear whether the differences in susceptibility between genera impact the outcome. According to published data [23] and our own results, treatment with penicillin may be preferable to ceftriaxone (particularly for Granulicatella), and vancomycin may be preferable to daptomycin.
The need for surgery was reported at around 27% in previous studies [24] . In our study, surgery (early or late) was performed in greater proportion: 67.6% and 65.8% in ABI IE and GRA IE, respectively. This may be explained, in part, by the subacute nature of the disease, and poor virulence, leading to advanced valve injury at diagnosis. In our institutional cases, the majority of surgery was early, performed during hospitalization.
As previously said, overall mortality was somehow similar to that described in the literature [10] for subacute IE of other etiologies, such as α-hemolytic Streptococcus. Interestingly, in previous reports [9, 19] , mortality was considered to be higher for ABI and GRA when compared with Streptococcus and Enterococcus species, but this was not observed in our study. It is possible that changes in isolation and identification of these pathogens provide a faster diagnosis and prompt therapy, leading consequently to a lower mortality rate. According to previous reports [20, 25] , age and new-onset cardiac failure were associated with poor prognosis for other causes of IE. These factors also remained associated to worse outcome for ABI and GRA. The genus, however, was not associated with higher mortality.
Our study has several limitations. First, the multiple changes in taxonomy have forced us to include only cases reported since 2000, excluding earlier cases. This decision was arbitrary, but it ensures correct genera classification, since the study design relied on the comparison of ABI and GRA. Second, the limited data reported on susceptibility to antibiotics and treatments regimens preclude us from obtaining more extensive conclusions regarding the optimal regimen. Another limitation is the publication bias; it is probable that cases with better outcome were reported more frequently, explaining in part the overall low mortality found. Finally, there is a referral bias related to the cardiac-surgery activity of our hospital. The indication for surgical treatment might be lower in other clinical settings.
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